UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Rediscovering nitroxoline: a metal-chelating agent bridging infection and cancer

Papareddy, Praveen; Mielke, Sophie RM; Graham, Marlowe; Bachmann, Dennis; Proschak, Ewgenij; Wichelhaus, Thomas A; Sander, Kerstin; (2025) Rediscovering nitroxoline: a metal-chelating agent bridging infection and cancer. Drug Discovery Today , 30 (8) , Article 104419. 10.1016/j.drudis.2025.104419. Green open access

[thumbnail of 1-s2.0-S1359644625001321-main-2.pdf]
Preview
PDF
1-s2.0-S1359644625001321-main-2.pdf - Accepted Version

Download (588kB) | Preview

Abstract

Nitroxoline, a legacy antimicrobial agent, is gaining attention for its potential repurposing in infectious diseases and oncology. Its broad-spectrum activity, including biofilm disruption and metal-chelating properties, supports diverse therapeutic applications. However, its systemic use is limited by rapid urinary excretion, short plasma half-life, and limited tissue distribution. In this review, we summarize recent advances in understanding the mechanisms of action, cross-kingdom activity, and anticancer effects of nitroxoline. Despite encouraging preclinical data, clinical translation is constrained by pharmacokinetic (PK) and regulatory challenges. As interest in repurposing established drugs grows, nitroxoline presents a compelling candidate for integration into modern therapeutic strategies across infectious and neoplastic disease domains.

Type: Article
Title: Rediscovering nitroxoline: a metal-chelating agent bridging infection and cancer
Location: England
Open access status: An open access version is available from UCL Discovery
DOI: 10.1016/j.drudis.2025.104419
Publisher version: https://doi.org/10.1016/j.drudis.2025.104419
Language: English
Additional information: This work is licensed under a Creative Commons License. The images or other third-party material in this article are included in the Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
Keywords: Science & Technology, Life Sciences & Biomedicine, Pharmacology & Pharmacy, nitroxoline, drug repurposing, antimicrobial resistance, metal chelation, biofilm disruption, cancer therapy, pharmacokinetics, GROWTH
UCL classification: UCL
UCL > Provost and Vice Provost Offices > UCL BEAMS
UCL > Provost and Vice Provost Offices > UCL BEAMS > Faculty of Maths and Physical Sciences
UCL > Provost and Vice Provost Offices > UCL BEAMS > Faculty of Maths and Physical Sciences > Dept of Chemistry
URI: https://discovery.ucl.ac.uk/id/eprint/10212855
Downloads since deposit
0Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item